Delivery Order SPE2DB24D9230-SPE2DB25FHVQT
Award Date 8/26/25
Potential Completion Date 9/17/25
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for 34 mg Nuplazid capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single line item fulfillment under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. DMS Pharmaceutical Group Inc., a woman-owned small business...
- On July 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order is expected to be completed by July 23, 2025, and represents a specific fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The vendor, a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order under a firm fixed-price contract with a ceiling value of $10,375.53. The order represents no set-aside designation and carries an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Nuplazid 34 mg capsules (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of October 1, 2025, represents a tactical pharmaceutical procurement executed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the vendor to...
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units), with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued on September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this work at its primary facility in...
- The Defense Logistics Agency awarded a $3,458.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 16, 2025, for the supply of Nuplazid 34 mg capsules (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,375.53 for 30 Nuplazid 34 mg capsules by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a continuation of pharmaceutical supply services to the Department of Defense healthcare system. The contract carries...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite...